Targeted & controlled bone healing

Kuros will develop its products through its own resources and where commercially appropriate in partnership and collaboration with other companies.

Areas of interest are:

Kuros is seeking to maximise value from its development programs and proprietary localized delivery technology. To achieve this Kuros is interested in:

  • Relationships with commercialization partners for its lead product candidates
  • Collaboration or partnership with entities around its technologies and/or specific product candidates

Kuros will develop its products through its own resources and where commercially appropriate in partnership and collaboration with other companies. Kuros has a flexible approach to deal structuring and aims to create relationships that maximize the value for both parties.

Please direct any inquiries to:

Alistair Irvine, PhD
Chief Business Officer
Tel: +41 79 472 6357

Email: bd@kurosbio.com 

Kuros Biosciences AG
Wagistrasse 25, 8952 Schlieren, Switzerland
Tel: +41 44 733 47 47   Fax: +41 44 733 47 40   Email: info@kurosbio.com

About Kuros

  1. Overview
  2. Executive Committee
  3. Board
  4. Careers

Products

  1. MagnetOs

Pipeline

  1. Pipeline
  2. Spinal fusion
    KUR-113
  3. Fracture repair
    KUR-111
    KUR-113
  4. Surgical Sealants
    Neuroseal (KUR-023)

Technologies

  1. Surface Science Technology
  2. Fibrin-Based
  3. Synthetic Cross-Linking Technology
  4. Immune Modulation

Partnerships

  1. Collaborations
  2. Business Development

Investors

  1. Share price
  2. Regulatory filings
  3. Reports & Presentations
  4. Analysts
  5. Calendar
  6. Corporate governance
  7. Stay informed

News

  1. Press releases
  2. Conferences & Events

Contact

  1. Location
Business Development

Kuros will develop its products through its own resources and where commercially appropriate in partnership and collaboration with other companies.

Areas of interest are:

Kuros is seeking to maximise value from its development programs and proprietary localized delivery technology. To achieve this Kuros is interested in:

  • Relationships with commercialization partners for its lead product candidates
  • Collaboration or partnership with entities around its technologies and/or specific product candidates

Kuros will develop its products through its own resources and where commercially appropriate in partnership and collaboration with other companies. Kuros has a flexible approach to deal structuring and aims to create relationships that maximize the value for both parties.

Please direct any inquiries to:

Alistair Irvine, PhD
Chief Business Officer
Tel: +41 79 472 6357

Email: bd@kurosbio.com